Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Citius Pharmaceuticals, Inc. (CTXR) had Return on Equity of -53.20% for the most recently reported fiscal year, ending 2024-09-30.
| Income Statement Financials | |
-- |
|
$-40.19M |
|
-- |
|
-- |
|
$42.00M |
|
$-42.00M |
|
$3.15M |
|
$-38.85M |
|
$-38.85M |
|
$-39.43M |
|
$-39.43M |
|
$-39.43M |
|
$-39.43M |
|
$-42.00M |
|
$-41.79M |
|
6.73M |
|
6.73M |
|
$-5.97 |
|
$-5.97 |
|
| Balance Sheet Financials | |
$14.22M |
|
-- |
|
$102.43M |
|
$116.65M |
|
$35.81M |
|
-- |
|
$6.74M |
|
$42.55M |
|
$74.10M |
|
$64.75M |
|
$74.10M |
|
7.25M |
|
| Cash Flow Statement Financials | |
$-28.20M |
|
$-5.00M |
|
$9.97M |
|
$26.48M |
|
$3.25M |
|
$-23.23M |
|
$11.84M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.40 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-28.20M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-53.20% |
-60.88% |
|
-33.80% |
|
-53.20% |
|
$10.22 |
|
$-4.19 |
|
$-4.19 |
|